The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles
Open accessAbstract
Paclitaxel (Taxol(®)) is an important anticancer drug in clinical use for treatment of a variety of cancers. Because of its low solubility, it is formulated in high concentration in Cremophor EL(®) which induces hypersensitivity reactions. In this study, targeted delivery of paclitaxel-loaded nanoparticles was prepared by a desolvation procedure, crosslinked on the wall material of bovine serum albumin, and subsequently decorated by folic acid. The characteristics of the nanoparticles, such as amount of folate conjugation, surface morphology, drug entrapment efficiency, drug loading efficiency, and release kinetics were investigated in vitro. The targeting effect was investigated in vitro by cancer cell uptake of fluorescein isothiocyanate-labeled nanoparticles. The spherical nanoparticles obtained were negatively charged with a zeta potential of about -30 mV, and characterized around 210 nm with a narrow size distribution. Drug entrapment efficiency and drug loading efficiency were approximately 95.3% and 27.2%, respectively. The amount of folate conjugation was 9.22 μg/mg of bovine serum albumin. The folate-decorated nanoparticles targeted a human prostate cancer cell line effectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Desolvation process and surface characterisation of protein nanoparticles
Weber, C., Coester, C., Kreuter, J., & Langer, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00370-1 · Cited by 603
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 510
Szebeni, J., Alving, C. R., & Muggia, F. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.4.300 · Cited by 341
Hydrotropic polymer micelle system for delivery of paclitaxel
Huh, K. M., Lee, S. C., Cho, Y. W., Lee, J., Jeong, J. H., & Park, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.003 · Cited by 291
Folate receptor endocytosis and trafficking
Sabharanjak, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.010 · Cited by 273
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties
Merodio, M., Arnedo, A., Renedo, M. J., & Irache, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00169-x · Cited by 233
High affinity binding of paclitaxel to human serum albumin
Paál, K., Müller, J., & Hegedûs, L. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02107.x · Cited by 191
Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles
Cho, Y. W., Lee, J., Lee, S. C., Huh, K. M., & Park, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.013 · Cited by 172
Paclitaxel Prodrugs: Toward Smarter Delivery of Anticancer Agents
Skwarczynski, M., Hayashi, Y., & Kiso, Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0602155 · Cited by 170
Suh, H., Jeong, B., Rathi, R. C., & Kim, S. W. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199811)42:2<331::aid-jbm19>3.0.co;2-l · Cited by 134
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells
Zhang, L., Hou, S., Mao, S., Wei, D., Song, X., & Lü, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.015 · Cited by 134
Zhang, Y., Tang, L., Sun, L., Bao, J., Song, C. X., Huang, L., Liu, K., Tian, Y., Tian, G., Li, Z., et al. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.11.035 · Cited by 134
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles
Seow, W. Y., Xue, J. M., & Yang, Y. Y. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.039 · Cited by 132
Meziani, M. J., & Sun, Y. (2003) · Journal of the American Chemical Society · doi:10.1021/ja030104k · Cited by 131
Risks and Benefits of Taxanes in Breast and Ovarian Cancer
Michaud, L. B., Valero, V., & Hortobágyi, G. N. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00005 · Cited by 121
Preparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate
Dosio, F., Brusa, P., Crosasso, P., Arpicco, S., & Cattel, L. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01656-8 · Cited by 116
Hattori, Y., & Maitani, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.007 · Cited by 102
Hattori, Y., & Maitani, Y. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700844 · Cited by 97
Production of biological nanoparticles from bovine serum albumin for drug delivery
Rahimnejad, M., Jahanshahi, M., & Najafpour, G. (2006) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2006.000-5072 · Cited by 91
The folate receptor as a potential therapeutic anticancer target
Gruner, B. A., & Weitman, S. D. (1998) · Investigational New Drugs · doi:10.1023/a:1006147932159 · Cited by 61
Temming, K., Meyer, D. L., Zabinski, R. F., Dijkers, E. C. F., Poelstra, K., Molema, G., & Kok, R. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060087z · Cited by 52
Temming, K., Meyer, D. L., Zabinski, R. F., Senter, P. D., Poelstra, K., Molema, G., & Kok, R. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp0700312 · Cited by 45
Dosio, F., Arpicco, S., Stella, B., Brusa, P., & Cattel, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.018 · Cited by 42
Zheng, Y., Song, X., Darby, M. V., Liang, Y., He, L., Cai, Z., Chen, Q., Bi, Y., Yang, X., Xu, J., et al. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.09.007 · Cited by 27
High-affinity folate binding in human prostate
Holm, J., Hansen, S. I., & Høier‐Madsen, M. (1993) · Bioscience Reports · doi:10.1007/bf01145962 · Cited by 13
Cited by
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Albumin-based nanoparticles as potential controlled release drug delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,520
Harnessing albumin as a carrier for cancer therapies
Hoogenboezem, E. N., & Duvall, C. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.011 · Cited by 610
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Paclitaxel Nano-Delivery Systems: A Comprehensive Review
Ma, P. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000164 · Cited by 559
Metadata
- Authors
- Zu
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2010-09
- Volume
- 5
- Pages
- 669
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2165391945
- Cited by
- 272
- References
- 33
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.